Artelo Biosciences Financial Statements 2014-2025 | ARTL

Revenue

Cost Of Goods Sold

Gross Profit

Research And Development Expenses

$5.993

$5.696

$4.324

$2.839

$1.919

$1.092

$1.25

SG&A Expenses

$4.115

$4.234

$5.963

$4.602

$2.767

$2.117

$1.093

$0.233

$0.03

Other Operating Income Or Expenses

Operating Expenses

Operating Income

$-10.108

$-9.93

$-10.287

$-7.441

$-4.686

$-3.21

$-2.344

$-0.233

$-0.03

Total Non-Operating Income/Expense

$0.282

$0.641

$0.204

$0.004

$0.029

$1.037

$-0.002

Pre-Tax Income

$-9.826

$-9.289

$-10.083

$-7.437

$-4.655

$-2.172

$-2.344

$-0.235

$-0.03

Income Taxes

Income After Taxes

$-9.826

$-9.289

$-10.083

$-7.437

$-4.655

$-2.172

$-2.344

$-0.235

$-0.03

Other Income

Income From Continuous Operations

$-9.826

$-9.289

$-10.083

$-7.437

$-4.655

$-2.172

$-2.344

$-0.235

$-0.03

Income From Discontinued Operations

Net Income

$-9.826

$-9.289

$-10.083

$-7.437

$-4.655

$-2.172

$-2.344

$-0.235

$-0.03

EBITDA

$-10.108

$-9.93

$-10.287

$-7.441

$-4.686

$-3.209

$-2.343

$-0.232

$-0.233

$-0.03

EBIT

$-10.108

$-9.93

$-10.287

$-7.441

$-4.686

$-3.21

$-2.344

$-0.233

$-0.03

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-3.05

$-3.14

$-3.56

$-5.97

$-18.89

$-14.99

$-27.59

$-0.45

EPS - Earnings Per Share

$-3.05

$-3.14

$-3.56

$-5.97

$-18.89

$-14.99

$-27.59

$-0.45